Circadian Function and Cardio-metabolic Risk in Adrenal Insufficiency
NCT ID: NCT03000231
Last Updated: 2024-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
86 participants
OBSERVATIONAL
2015-10-31
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiovascular Status in Adrenal Insufficiency
NCT03426319
Predisposing Factors for the Incidence of Adrenal Crisis
NCT03410160
Study to Investigate Adrenal Crisis (Six-year Follow-up)
NCT03499990
Cardiovascular Status in Patients With Endogenous Cortisol Excess (Cushing's Syndrome)
NCT03880513
Prospective Study on the Incidence of Adrenal Crisis in Patients With Chronic Adrenal Insufficiency
NCT01184209
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A secondary hypothesis of the study is that adrenal insufficiency patients on a replacement regimen (as part of their standard of care ongoing treatment) that results in daytime cortisol profiles approximating the normal diurnal variation will have better cardio-metabolic function than adrenal insufficiency patients who have grossly abnormal cortisol profiles.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy Controls
Matched by age, race, gender and BMI to adrenal insufficiency subjects
No interventions assigned to this group
Adrenal Insufficiency Patients
Eligible patients will have either primary adrenal insufficiency or secondary adrenal insufficiency and will be age 18 and older.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eve Van Cauter, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Chicago
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of Chicago
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-1484
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.